Pregnancy & Lactation : הריון/הנקה

4.6       Fertility, pregnancy and lactation

Pregnancy
There are limited data from the use of clobetasone in pregnant women.
Topical administration of corticosteroids to pregnant animals can cause abnormalities of foetal development (see section 5.3).
The relevance of this finding to humans has not been established. Administration of clobetasone during pregnancy should only be considered if the expected benefit to the 
mother outweighs the risk to the foetus. The minimum quantity should be used for the minimum duration.

Breast-feeding
The safe use of topical corticosteroids during lactation has not been established.
It is not known whether the topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable amounts in breast milk.
Administration of clobetasone during lactation should only be considered if the expected benefit to the mother outweighs the risk to the infant.
If used during lactation, clobetasone should not be applied to the breasts to avoid accidental ingestion by the infant.

Fertility
There are no data in humans to evaluate the effect of topical corticosteroids on fertility.